Invitation - Presentation of Sobi's third quarter results 2015

Invitation - Presentation of Sobi's third quarter results 2015

ID: 427992

(Thomson Reuters ONE) -


On 29 October, at 08:00 CET, Swedish Orphan Biovitrum AB (publ) (Sobi) will
publish its report for the third quarter 2015.

Financial analysts and media are invited to participate in a telephone
conference, which will include a presentation of the results, on the same day at
14:00 CET. The event will be hosted by Sobi's CEO and President, Geoffrey
McDonough, and the presentation will be held in English.

The presentation can be followed live, or afterwards on www.sobi.com. Slides
used in the presentation will be made available on our website prior to the
telephone conference.

To participate in the telephone conference, please call:

UK: +44 20 3428 1408
SE: +46 8 5664 2701
US: +1 866 388 1925

Live audience URL:
http://event.onlineseminarsolutions.com/r.htm?e=1063523&s=1&k=DBB6DBFA102893B9DA
628105B6545C73
(The recording will be made available via the audience URL within three hours
after the live broadcast using the same link.)



---



About Sobi
Sobi is an international specialty healthcare company dedicated to rare
diseases. Our mission is to develop and deliver innovative therapies and
services to improve the lives of patients. The product portfolio is primarily
focused on Haemophilia, Inflammation and Genetic diseases. We also market a
portfolio of specialty and rare disease products for partner companies across
Europe, the Middle East, North Africa and Russia. Sobi is a pioneer in
biotechnology with world-class capabilities in protein biochemistry and
biologics manufacturing. In 2014, Sobi had total revenues of SEK 2.6 billion
(USD 380 M) and about 600 employees. The share (STO: SOBI) is listed on NASDAQ
OMX Stockholm. More information is available at www.sobi.com.



For more information please contact

Media relations  Investor relations





Oskar Bosson, Head of Jörgen Winroth, Vice President, Head of Investor
Communications Relations

T: +46 70 410 71 80 T: +1 347-224-0819, +1 212-579-0506, +46 8 697 2135

oskar.bosson(at)sobi.com jorgen.winroth(at)sobi.com



040e_Earnings call invitation Q3 2015:
http://hugin.info/134557/R/1959956/714378.pdf



This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Swedish Orphan Biovitrum AB (publ) via GlobeNewswire
[HUG#1959956]




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Prosafe SE: Q3 2015 results and webcast/teleconference on 4 November 2015 Delisting from the regulated market of Euronext Brussels of the attribution rights of Financière de Tubize (ISIN TUBAT BE0099967573)
Bereitgestellt von Benutzer: hugin
Datum: 20.10.2015 - 08:00 Uhr
Sprache: Deutsch
News-ID 427992
Anzahl Zeichen: 3064

contact information:
Town:

Stockholm



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 267 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Invitation - Presentation of Sobi's third quarter results 2015"
steht unter der journalistisch-redaktionellen Verantwortung von

Swedish Orphan Biovitrum AB (publ) (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Swedish Orphan Biovitrum AB (publ)



 

Werbung



Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z